{"id":"W2551016480","doi":"10.1182/blood.v110.11.3420.3420","title":"Preliminary Pharmacokinetic (PK) Analysis of Eastern Cooperative Oncology Group Protocol E4402: Rituximab Extended Schedule or Re-Treatment Trial (RESORT).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Dosing; Internal medicine; Clinical endpoint; Randomized controlled trial; Neutropenia; Gastroenterology; Lymphoma; Randomization; Urology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008171566,0.001091191,0.001328596,0.0003268705,0.0004297522,0.00112834,0.001441419,0.002091742,0.01807321],"category_scores_gemma":[0.007051692,0.0006048448,0.001239056,0.0005917904,0.000572587,0.0009506796,0.0004918927,0.003515173,0.002899122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001162678,"about_ca_system_score_gemma":0.003944579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008259282,"about_ca_topic_score_gemma":0.002260549,"domain_scores_codex":[0.9970433,0.002208337,0.0001480329,0.0001841417,0.0001725656,0.0002436394],"domain_scores_gemma":[0.9965803,0.0009978169,0.0006132373,0.000515495,0.0005273196,0.0007657469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9265499,0.009593512,0.002148276,0.0009408128,0.0008560179,0.0001983237,0.0001301099,0.001267916,0.006330339,0.0007805338,0.02273444,0.02846992],"study_design_scores_gemma":[0.8675801,0.0993252,0.01004939,0.0001064644,0.00038171,0.0001467203,0.00003183307,0.001235311,0.001312973,0.000638938,0.01916175,0.00002963955],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6233782,0.003842807,0.009601627,0.006051012,0.001116765,0.2440249,0.06769945,0.001094961,0.04319023],"genre_scores_gemma":[0.6870925,0.001875711,0.01628768,0.008688454,0.0005344346,0.2040941,0.05846315,0.0002229779,0.0227408],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01807321,"threshold_uncertainty_score":0.06046087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02369911680455644,"score_gpt":0.3458533971926748,"score_spread":0.3221542803881183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}